Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillipp Hartmann

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 16, 2019
Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful eitherPhillipp Hartmann, Huikuan Chu, Yi Duan, et al.
JPGN Reports|May 17, 2024
Collagenous gastritis with elevated fecal calprotectin in a pediatric patientNatalie Rodriguez, Soma Kumar, Jun Mo, et al.
Hepatology (Baltimore, Md.)|April 6, 2023
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019Phillipp Hartmann, Xinlian Zhang, Rohit Loomba, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 2, 2023
Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver diseaseBenedikt Kaufmann, Nick Seyfried, Daniel Hartmann, et al.
Microorganisms|November 27, 2025
Serum Levels of <i>Candida albicans</i> 65-kDa Mannoprotein (CaMp65p) Correlate with Liver Disease in Patients with Alcohol Use DisorderJulia T Schnabl, Silvia Sandini, Peter Stärkel, et al.
Gastroenterology|July 31, 2012
Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in micePhillipp Hartmann, Michael Haimerl, Magdalena Mazagova, et al.
Journal of Hepatology|October 11, 2018
Reply to: "Finding fibroblast growth factor 19 during cholestasis: Does x mark the spot?Katharina Brandl, Phillipp Hartmann, Lily J Jih, et al.
Pediatrics|August 16, 2021
Complete Absence of the Extrahepatic Biliary Tree in a Newborn With Pigmented StoolsPhillipp Hartmann, Rebecca Carter, Benjamin Keller, et al.
Journal of Immunological Methods|January 18, 2015
Methods to determine intestinal permeability and bacterial translocation during liver diseaseLirui Wang, Cristina Llorente, Phillipp Hartmann, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 17, 2023
Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failurePhillipp Hartmann, Sonja Lang, Robert Schierwagen, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 16, 2019
Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful eitherPhillipp Hartmann, Huikuan Chu, Yi Duan, et al.
JPGN Reports|May 17, 2024
Collagenous gastritis with elevated fecal calprotectin in a pediatric patientNatalie Rodriguez, Soma Kumar, Jun Mo, et al.
Hepatology (Baltimore, Md.)|April 6, 2023
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019Phillipp Hartmann, Xinlian Zhang, Rohit Loomba, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 2, 2023
Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver diseaseBenedikt Kaufmann, Nick Seyfried, Daniel Hartmann, et al.
Microorganisms|November 27, 2025
Serum Levels of <i>Candida albicans</i> 65-kDa Mannoprotein (CaMp65p) Correlate with Liver Disease in Patients with Alcohol Use DisorderJulia T Schnabl, Silvia Sandini, Peter Stärkel, et al.
Gastroenterology|July 31, 2012
Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in micePhillipp Hartmann, Michael Haimerl, Magdalena Mazagova, et al.
Journal of Hepatology|October 11, 2018
Reply to: "Finding fibroblast growth factor 19 during cholestasis: Does x mark the spot?Katharina Brandl, Phillipp Hartmann, Lily J Jih, et al.
Pediatrics|August 16, 2021
Complete Absence of the Extrahepatic Biliary Tree in a Newborn With Pigmented StoolsPhillipp Hartmann, Rebecca Carter, Benjamin Keller, et al.
Journal of Immunological Methods|January 18, 2015
Methods to determine intestinal permeability and bacterial translocation during liver diseaseLirui Wang, Cristina Llorente, Phillipp Hartmann, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 17, 2023
Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failurePhillipp Hartmann, Sonja Lang, Robert Schierwagen, et al.
Pageof 7